Know Cancer

or
forgot password

Clinical Utility of the Alaris MidLatencyAuditoryEvoked Potentials Monitor to Titrate the Anesthetic-Hypnotic Component of Anesthesia


Phase 3
18 Years
65 Years
Not Enrolling
Both
Scheduled General Anesthesia

Thank you

Trial Information

Clinical Utility of the Alaris MidLatencyAuditoryEvoked Potentials Monitor to Titrate the Anesthetic-Hypnotic Component of Anesthesia


Inclusion Criteria:



- ASA status I-II patients

- aged 18 - 65 years

- scheduled for general surgery (except laparoscopic interventions) lasting longer than
1 hour.

Exclusion Criteria:

- Body weight < 70% or > 150% ideal body weight

- neurological disorder and hearing disorders (being not able to communicate with the
patient in a normal tone)

- use of any medication interfering with pharmacological effect of the study including
alcohol misuse or drugs.

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Influence of AEP guided anesthesia on recovery delay

Principal Investigator

Michel STRUYS, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

CHU de GENT - BELGIUM

Authority:

France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Study ID:

PEA

NCT ID:

NCT00181051

Start Date:

February 2003

Completion Date:

Related Keywords:

  • Scheduled General Anesthesia

Name

Location